SB-715992

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for SB-715992, covering 2008-10-16 to 2023-08-04. Get the full timeline:

Most recent: Clinical Trial Update: SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer [Phase 2]